Skip to main content
Ipsen Home Page
Press shift tab to select search category
Loading...
  • Media arrow down
      < Back
    • Media
    • Press Releases
    • Media Statements
    • Media Library
  • Investors arrow down
      < Back
    • Investors
    • Investors
    • Financial Results
    • Corporate News
    • Financial Calendar
    • Investor Events
    • Reports and Accounts
    • Shareholders Information
    • Regulated Information
    • Five-Year Stock Information
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
    • Culture
  • Press shift tab to select search category
    Loading...
  • Global Nordics
    < Back
    • Global
    • Annual Report
    • Americas
    • Asia Pacific
    • Europe
    • Middle East & Africa
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Slovakia
    • Czech Republic
    • Austria
    • Switzerland
    • UAE & Gulf
  • Home
  • Companyarrow down
      < Back
    • Company
    • Company
    • Leadership
    • History
    • Fondation Ipsen
  • Sciencearrow down
      < Back
    • Science
    • Oncology
    • Rare Disease
    • Neuroscience
    • Products
    • R&D
    • Pipeline
    • Clinical Trials
    • Lay Summaries
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • Patients
    • People
    • Governance
    • Transparency in Relations and Interests
  • Patientsarrow down
      < Back
    • Patients
    • Patients
    • Together for Oncology
    • Together for Rare Disease
    • Together for Neuroscience
    • Lay Language Summaries
    • Collaborate with us
  • Stories
Linkedin Twitter Facebook Instagram Youtube
  • Terms and Conditions
  • Cookie Policy
  • Nordics Privacy Policy
  • Contact Us

Copyright © Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen group website.To continue, please click on Continue?

Continue